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General. All reactions were carried out under Ar in pre-dried glassware using Schlenk 
techniques. The solvents were dried by distillation over the drying agents indicated and were 
stored and transferred under Ar: CH2Cl2 (P4O10), toluene (Na/K), THF (magnesium/ 
anthracene). Flash chromatography: Merck silica gel (230-400 mesh). NMR: Spectra were 
recorded on a Bruker DPX 300 spectrometer in the solvent indicated. Chemical shifts (δ) are 
given in ppm relative to TMS, coupling constants (J) in Hz. IR: Nicolet Magna 750 FT-IR, 
wavenumbers in cm-1. MS: Finnigan MAT 8200 (70 eV); HR-MS: Finnigan MAT 95. 
Elemental analyses: Dornis & Kolbe, Mülheim. Commercially available reagents (Aldrich, 
Fluka) were used as received. 
 
Representative Procedure for ACM: 2-(5-Chloro-pent-1-ynyl)-benzoic acid methylester: 
To a solution of complex 1 (57 mg, 0.092 mmol) in toluene (10 mL) and CH2Cl2 /LV
added 2-prop-1-ynyl-benzoic acid methyl ester 6 (160 mg, 0.91 mmol) and 1,8-dichloro-oct-
4-yne 2 (247 mg, 1.38 mmol) and the resulting solution is stirred at 80°C for 8 h. After 
evaporation of the solvent, the residue is chromatographed (first toluene, then hexanes/ethyl 
acetate 15:1) affording the title compound as a colorless oil (135 mg, 62 %). IR 3068, 2995, 
2951, 2874, 2227, 1730, 1485, 1433, 1294, 1252, 1130, 1085, 758; 1H NMR (CD2Cl2, 300 
0+] GGJ = 7.9, 1.3 Hz, 1H), 7.49 (ddt, J = 15.2, 7.8, 1.5 Hz, 2H), 7.37 (dt, J = 7.5, 
1.6 Hz, 1H), 3.91 (s, 3 H), 3.81 (t, J = 6.4 Hz, 2 H), 2.68 (t, J = 6.7 Hz, 2 H), 2.09 (q, J = 6.6 
Hz, 2 H); 13C NMR (CD2Cl20+] 32.6, 131.9, 130.4, 127.8, 124.2, 
93.9, 80.3, 52.3, 44.3, 31.8, 17.4; MS (EI) m/z (rel intensity) 236 (1), 201 (6), 187 (2), 174 
(100), 159 (16), 143 (8), 131 (7), 115 (12); HR-MS (C13H13O2Cl+H): calcd. 237.068232; 
 S-2
found 237.068136. Anal. calcd. for C13H13O2Cl (236.69): C, 65.97; H, 5.54; found C, 65.79; 
H, 5.46. 
 
The following compounds have been prepared analogously: 
 
3,3’-Bis(trifluoromethyl)-acetylene: IR 3077, 2926, 2857, 1609, 1587, 1493, 1440, 1348, 
1165, 1128, 1070, 1913, 805, 694;  1H NMR (CD2Cl2, 0+] V+G J = 
7.7 Hz, 2H), 7.66 (d, J = 7.9 Hz, 2H), 7.56 (t, J = 7.8 Hz, 2H); 13C NMR (CD2Cl2, 75 MHz): 
06(,m/z (rel intensity) 314 (100), 
295 (15), 264 (4), 245 (4), 225 (6), 194 (2), 176 (3), 169 (3), 157 (4), 147 (3), 132 (1), 99 (1), 
75 (1); HR-MS (C16H8F6): calcd. 314.053018, found 314.053135. 
1-(5-Chloro-pent-1-ynyl)-3-trifluoromethyl-benzene: IR 3078, 2999, 2962, 2846, 2233, 
1433, 1337, 1167, 1129, 1073, 902, 801, 696, 1602; 1H NMR (CD2Cl2, 300 MHz):  7.69 (s, 
1H), 7.61 (d, J = 7.7 Hz, 1H), 7.57 (d, J = 8.0 Hz, 1H), 7.46 (dd, J = 7.6 Hz, 1H), 3.75 (t, J = 
6.4 Hz, 2H), 2.65 (t, J = 6.9 Hz, 2H), 2.11 (quint., J = 6.6 Hz, 2H); 13C NMR (CD2Cl2, 75 
MHz):  135.2, 131.0, 129.3, 128.7, 124.8, 124.6, 124.3, 90.5, 80.3, 44.2, 31.7, 17.1; MS (EI) 
m/z (rel intensity) 246 (47), 227 (13), 211 (100), 191 (44), 183 (97), 142 (32), 133 (26), 115 
(20), 87 (8), 75 (8), 63 (14); HR-MS (C12H10F3Cl): calcd. 246.042312, found 246.042480. 
Anal. calcd. for C12H10F3Cl (246.66): C, 58.43; H, 4.09; found C, 58.60; H, 3.98.  
4,4’-Ethynediyl-di-benzonitrile: IR 3058, 2920, 2225, 1928, 1675, 1606, 1502, 1408, 1273, 
1182, 1022, 841, 553;  1H NMR (CD2Cl2, 300 MHz):  7.61 (dd, J = 8.5, 1.8 Hz, 4H), 7.57 
(dd, J = 8.5, 1.8 Hz, 4H); 13C NMR (CD2Cl2, 75 MHz): 
91.4; MS (EI) m/z (rel intensity) 228 (100), 201 (8), 175 (4), 151 (3), 137 (1), 100 (3), 87 (4), 
74 (3), 63 (1). 
4-(5-Chloro-pent-1-ynyl)-benzonitrile: IR 3091, 3059, 2960, 2926, 2227, 1604, 1501, 1291, 
1177, 840, 657, 555; 1H NMR (CD2Cl2, 300 MHz):  7.69 (s, 1H), 7.61 (d, J = 8.5Hz, 2H), 
7.50 (d, J = 8.5 Hz, 2H), 3.74 (t, J = 6.4 Hz, 2H), 2.66 (t, J = 6.9 Hz, 2H), 2.11 (quint., J = 6.6 
Hz, 2H); 13C NMR (CD2Cl2, 75 MHz):  132.4, 132.4, 128.9, 118.8, 111.5, 93.6, 80.4, 44.2, 
31.5, 17.2; MS (EI) m/z (rel intensity) 203 (37), 168 (100), 153 (27), 140 (77), 127 (14), 113 
(18), 87 (5), 75 (5), 63 (12); HR-MS (C12H10NCl): calcd. 203.050177, found 203.05025. 
Anal. calcd. for C12H10NCl (203.67): C, 70.77; H, 4.95; N, 6.88; found C, 70.85; H, 4.95; N, 
6.94.  
Bis-(2-methoxy-phenyl)-acetylene: IR 3104, 3075, 3031, 2998, 2964, 2937, 2832, 1598, 
1573, 1500, 1465, 1433, 1276,  1242, 1116, 1021, 753; 1H NMR (CD2Cl2, 300 MHz):  7.50 
(dd, J = 8.0, 1.8 Hz, 1H), 7.35 (m, 1H), 6.97 (m, 2H), 3.94 (s, 3H); 13C NMR (CD2Cl2, 75 
MHz):  160.3, 133.7, 130.1, 120.8, 112.9, 111.2, 90.0, 56.2; MS (EI) m/z (rel intensity) 238 
(100), 223 (22), 207 (10), 195 (5), 178 (8), 165 (19), 152 (13), 131 (26), 119 (5), 89 (5), 76 
(6), 63 (5); HR-MS (C16H14O2): calcd. 238.099379, found. 238.099436. 
 S-3
1-(5-Chloro-pent-1-ynyl)-2-methoxy-benzene (10b): IR 3074, 3004, 2940, 2248, 1596, 
1493, 1434, 1261, 1117, 1024, 755; 1H NMR (CD2Cl2, 300 MHz):  7.36 - 7.27 (m, 2H), 
6.94 - 6.9 (m, 2H), 3.87 (s, 3H), 2.64 (t, J = 6.7 Hz, 2H), 2.61 (t, J = 7.2 Hz, 2H), 1.97 (quint., 
J = 7.0 Hz, 2H); 13C NMR (CD2Cl2, 75 MHz): 160.5, 133.6, 129.2, 120.7, 119.8, 112.8, 
111.0, 91.6, 78.8, 56.0, 25.2, 19.0, 16.4; MS (EI) m/z (rel intensity) 208 (100), 173 (35), 158 
(31), 131 (62), 115 (67), 102 (14), 91 (35), 77 (13), 63 (15), 51 (13); HR-MS (C12H13OCl): 
calcd. 208.065493, found 208.065321. Anal. calcd. for C12H13OCl (208.68): C, 69.07; H, 
6.28; found C, 69.20; H, 6.24.  
Bis-(2-methoxycarbonyl-phenyl)-ethyne: IR 3073, 2985, 2849, 2844, 1722, 1567, 1493, 
1435, 1256, 1084, 964, 760, 696;  1H NMR (CD2Cl2, 300 MHz):  7.99 (dd, J = 7.8, 1.3 Hz, 
1H), 7.72 (dd, J = 7.6, 1.3 Hz 1H), 7.56 (dt, J = 7.5, 1.4 Hz, 1H), 7.45 (dt, J = 7.7, 1.4 Hz, 
1H), 3.96 (s, 3H); 13C NMR (CD2Cl2, 75 MHz): 166.8, 134.5, 132.4, 132.1, 130.7, 128.6, 
124.0, 93.3, 52.5; MS (EI) m/z (rel intensity) 294 (10), 279 (100), 264 (24), 248 (20), 220 
(17), 208 (3), 192 (2), 176 (7), 163 (10), 132 (8), 116 (4), 102 (7), 88 (9), 75 (4), 59 (2); HR-
MS (C18H14O4): calcd. 294.089208, found 294.089107. Anal. calcd. for C18H14O4 (294.09): 
C, 73.46; H, 4.79; found C, 73.55; H, 4.72.  
2-(5-Chloro-pent-1-ynyl)-benzoic acid methyl ester: IR 3068, 2995, 2951, 2874, 2227, 
1730, 1485, 1433, 1294, 1252, 1130, 1085, 758; 1H NMR (CD2Cl2, 300 MHz):  7.89 (dd, J 
= 7.9, 1.3 Hz, 1H), 7.49 (ddt, J = 15.2, 7.8, 1.5 Hz, 2H), 7.37 (dt, J = 7.5, 1.6 Hz, 1H), 3.91 (s, 
3 H), 3.81 (t, J = 6.4 Hz, 2 H), 2.68 (t, J = 6.7 Hz, 2H), 2.09 (quint., J = 6.6 Hz, 2H); 13C 
NMR (CD2Cl2, 75 MHz):  167.0, 134.4, 132.6, 131.9, 130.4, 127.8, 124.2, 93.9, 80.3, 52.3, 
44.3, 31.8, 17.4; MS (EI) m/z (rel intensity) 236 (1), 201 (6), 187 (2), 174 (100), 159 (16), 143 
(8), 131 (7), 115 (12), 102 (6), 88 (3), 74 (2); HR-MS (C13H14O2Cl+H): calcd. 237.068232, 
found 237.068136. Anal. calcd. for C13H13O2Cl (236.69): C, 65.97; H, 5.54; found C, 65.79; 
H, 5.46.  
Tolan-4,4’-bis-carbaldehyde: IR 3059, 2846, 2742, 1702, 1602, 1562, 1385, 1300, 1205, 
1161, 862, 827, 792; 1H NMR (CD2Cl2, 300 MHz): V+GJ = 8.3 Hz, 2H), 
7.75 (d, J = 8.3 Hz, 2H); 13C NMR (CD2Cl20+] 
92.3; MS (EI) m/z (rel intensity) 234 (100), 205 (9), 176 (30), 151 (10), 116 (5), 102 (4), 88 
(7), 75 (5), 63 (2), 51 (3); HR-MS (C16H10O2): calcd. 234.068079, found 234.067917. Anal. 
calcd. for C16H10O2 (234.07): C, 82.04; H, 4.30; found C, 82.11; H, 4.33.  
4-(5-Chloro-pent-1-ynyl)-benzaldehyde: IR 2963, 2932, 2870, 2731, 2229, 1702, 1602,  
1473, 1390, 1207, 1166, 829; 1H NMR (CD2Cl2, 300 MHz):  10.05 (s, 1H), 7.82 (d, J = 8.4 
Hz, 2H), 7.57 (d, J = 8.3 Hz, 2H), 3.75 (t, J = 6.4 Hz, 2H), 2.67 (t, J = 6.9 Hz, 2H), 2.09 
(quint., J = 6.5 Hz, 2H); 13C NMR (CD2Cl2, 75 MHz):  191.7, 135.7, 132.5, 130.3, 129.8, 
93.2, 81.1, 44.2, 31.7, 17.3; MS (EI) m/z (rel intensity) 206 (96), 171 (59), 143 (87), 128 (91), 
115 (100), 101 (6), 89 (13), 75 (11), 63 (26), 51 (14), 39 (14); HR-MS (C12H11OCl): calcd. 
206.049843, found 206.049898. Anal. calcd. for C12H11OCl (206.67): C, 69.74; H, 5.36; 
found C, 69.88; H, 5.43.  
 S-4
2-(5-Chloro-pent-1-ynyl)-thiophene: IR 3106, 2959, 2921, 2848, 2225, 1518, 1428, 1289, 
1191, 1043, 851, 701; 1H NMR (CD2Cl2, 300 MHz):  7.24 (dd, J = 5.1, 1.1 Hz, 1H), 7.16 
(dd, J = 3.6, 0.8 Hz, 1H), 6.98 (dd, J = 5.2 Hz, 1H), 3.73 (t, J = 6.4 Hz, 2H), 2.65 (t, J = 6.9 
Hz, 2H), 2.09 (quint., J = 6.6 Hz, 2H); 13C NMR (CD2Cl2, 75 MHz):  131.6, 127.2, 126.6, 
124.0, 92.7, 74.7, 44.3, 31.7, 17.4; MS (EI) m/z (rel intensity) 184 (62), 149 (51), 134 (22), 
121 (100), 115 (42), 108 (4), 91 (86), 77 (24), 69 (12), 63 (14), 51 (10), 45 (15); Found: C, 
58.40; H, 5.32. HR-MS (C9H9Cl4S): calcd. 184.011351, found 184.011459.  
1-Hex-1-ynyl-2-methoxy-benzene (10a): IR 3074, 3002, 2957, 2933, 2872, 2232, 1596, 
1493, 1262, 1171, 1027, 750; 1H NMR (CD2Cl2, 300 MHz):  7.36 (dd, J = 7.8, 1.8 Hz, 1H), 
7.27(dt, J = 8.2, 1.8 Hz, 1H), 6.90 (m, 2H), 3.87 (s, 3H), 2.47 (t, J = 6.9 Hz, 2H), 1.65 - 1.47 
(m, 4H), 0.98 (t, J = 7.2 Hz, 3H); 13C NMR (CD2Cl2, 75 MHz): 160.3, 133.8, 129.2, 120.6, 
113.5, 111.0, 94.8, 77.0, 56.0, 31.3, 22.4, 19.6, 13.8; MS (EI) m/z (rel intensity) 188 (100), 
173 (45), 159 (35), 145 (30), 131 (46), 115 (52), 107 (10), 91 (34), 77 (11), 63 (9), 51 (7); 
HR-MS (C13H16O): calcd. 188.120115, found 188.120241. Anal. calcd. for C13H16O 
(188.12): C, 82.94; H, 8.57; found C, 82.75; H, 8.65.  
6-(2-Methoxy-phenyl)-hex-5-yne-nitrile (10c): IR 3074, 3004, 2940, 2837, 2248, 1596, 
1493, 1434,1261, 1117, 1024, 755; 1H NMR (CD2Cl2, 300 MHz):  7.38 (dd, J =7.8, 1.8 Hz, 
1H), 7.30 (td, J =7.8, 1.8 Hz, 1H), 6.94 - 6.88 (m, 2H), 3.87 (s, 3H), 2.64 (t, J = 6.8 Hz, 2H), 
2.61 (t, J = 7.2 Hz, 2H),  1.97 (quint., J = 7.0 Hz, 2H); 13C NMR (CD2Cl2, 75 MHz): 160.5, 
133.6, 129.7, 120.7, 119.8, 112.8, 111.0, 91.6, 78.8, 56.0, 25.2, 19.1, 16.4; MS (EI) m/z (rel 
intensity) 199 (100), 184 (7), 171 (30), 157 (13), 144 (26), 131 (22), 115 (49), 102 (9), 91 
(19), 77 (8), 68 (22), 63 (11), 51 (8), 39 (9); HR-MS (C13H13NO): calcd. 199.099714, found 
199.099461. Anal. calcd. for C13H13NO (199.10): C, 78.36; H, 6.58; N, 7.03; found C, 78.30; 
H, 6.52; N, 7.09.  
2-[6-(2-Methoxy-phenyl)-hex-5-ynyloxy]-tetrahydro-pyran (10d): IR 3073, 2941, 2868, 
2792, 2233, 2051, 1596, 1493, 1464 1261, 1118, 1033, 752; 1H NMR (CD2Cl2, 300 MHz):  
7.32 (dd, J = 7.8, 1.8 Hz, 1H), 7.25 (dt, J = 8.2, 1.8 Hz, 1H), 6.90 (m, 2H), 4.50 (t, J = 3.2Hz, 
1H), 3.86 (s, 3H), 3.87- 3.74 (m, 2H), 3.50- 3.43 (m, 2H), 2.51 (t, J = 6.9Hz, 2H), 1.81 - 1.69 
(m, 10H); 13C NMR (CD2Cl2, 75 MHz): 160.3, 133.8, 129.3, 120.6, 113.5, 111.0, 99.1, 94.5, 
77.2, 67.2, 62.4, 56.0, 31.2, 29.4, 26.1, 26.0, 20.0, 19.8; MS (EI) m/z (rel intensity) 288 (9), 
257 (3), 217 (13), 204 (10), 188 (4), 172 (11), 158 (8), 145 (9), 131 (10), 115 (18), 85 (100), 
67 (13), 57 (14), 41 (16); HR-MS (C18H24O3): calcd. 288.172544, found 288.172475. Anal. 
calcd. for C18H24O3 (288.17): C, 74.79; H, 8.39; found C, 74.88; H, 8.48.  
(4-Benzosulfonyl-but-1-ynyl)-benzene (13): IR 3062, 2918, 2240, 1585, 1491, 1447, 1308, 
1151, 1086, 759, 731, 689, 594, 528; 1H NMR (CD2Cl2, 300 MHz):  7.95 (d,  J = 8.1Hz, 
2H), 7.7 – 7.58 (m, 3H), 7.30 (s, 5H), 3.34 (t,  J = 7.3 Hz, 2H), 2.86 (t,  J = 7.9 Hz, 2H) ; 13C 
NMR (CD2Cl2, 75 MHz):  139.1, 134.3, 131.8, 129.8, 128.6, 128.5, 123.2, 85.3, 82.5, 55.0, 
14.6 ; MS (EI) m/z (rel intensity) 270 (2), 178 (2), 128 (100), 102 (5), 77 (11), 51 (7); HR-MS 
 S-5
(C16H14O2S+H): calcd. 271.079277, found 271.079062. Anal. calcd. for C16H14O2S 
(270.07): C, 71.08; H, 5.22; found C, 71.18; H, 5.29.  
Hex-1-ynyl-benzene (15a): IR  3080, 3055, 2958, 2872, 2231, 1598, 1490, 1465, 1070, 912, 
755, 691; 1H NMR (CD2Cl20+] – 7.39 (m, 2H), 7.36 – 7.29 (m, 3H), 2.45 (t, J 
= 6.9, 2H), 1.68 – 1.46 (m, 4H), 0.99 (t, J = 7.2 Hz, 3H); 13C NMR (CD2Cl20+] 
131.8, 128.6, 127.8, 124.5, 90.8, 80.7, 31.3, 22.4, 19.4, 13.8; MS (EI) m/z (rel intensity)  158 
(33), 143 (53), 129 (59), 115 (100), 102 (17), 89 (15), 77 (8), 63 (11), 51 (8), 39 (9). 
1-Hex-1-ynyl-4-methoxy-benzene (15b): IR  3002, 2957, 2934, 2232, 1596, 1493, 1464, 
1262, 1120, 1027, 751; 1H NMR (CD2Cl20+] GJ = 9.2 Hz, 2H), 6.81(d, J = 
9.2 Hz, 2H), 3.80 (s, 3H), 2.40 (t, J = 7.0 Hz, 2H), 1.70 - 1.30 (m, 4H), 0.94 (t, J = 7.1 Hz, 
2H); 13C NMR (CD2Cl20+] 
19.1, 13.6; MS (EI) m/z (rel intensity)  188 (100), 173 (45), 159 (35), 145 (30), 131 (46), 115 
(52), 107 (10), 91 (34), 77 (11), 63 (9), 51 (7). 
4-(Hex-1-ynyl)-benzoic acid ethyl ester (15c): IR 2959, 2934, 2873, 2230, 1719, 1607, 
1465, 1272, 1106, 858, 770, 697; 1H NMR (CD2Cl20+] GJ = 8.5 Hz, 2H), 
7.46 (d, J = 8.5 Hz, 2H), 4.36 (q, J = 7.1 Hz, 2H), 2.46 (t, J = 6.9 Hz, 2H), 1.67 - 1.44 (m, 4 
H), 1.39 (t, J = 7.1 Hz, 3 H), 0.97 (t, J = 7.3 Hz, 3H); 13C NMR (CD2Cl20+] 
131.7, 129.8, 129.6, 129.2, 94.3, 80.2, 61.4, 31.1, 22.4, 19.5, 14.5, 13.8; MS (EI) m/z (rel 
intensity) 230 (87), 215 (40), 201 (12), 185 (87), 173 (6), 157 (81), 143 (34), 129 (100), 115 
(42), 101 (6),  91 (13), 77 (11), 63 (10), 29 (43); HR-MS (C15H18O2): calcd. 230.130679, 
found 230.130827. Anal. calcd. for C15H18O2 (230.13): C, 78.16; H, 7.82; found C, 78.22; H, 
7.76.  
1-Cyano-9-(tetrahydro-pyran-2-yloxy)-non-4-yne: IR 2942, 2867, 2247, 1454, 1352, 1201, 
1137, 1120, 1076, 1034, 986, 905, 869, 814; 1H NMR (CD2Cl2, 300 MHz):  4.56 (t, J = 3.4 
Hz, 1H), 3.89 – 3.77 (m, 1H), 3.76 – 3.69 (m, 1H), 3.50 – 3.43 (m, 1H), 3.42 – 3.35 (m, 1H), 
2.49 (t, J = 7.2 Hz, 2 H), 2.36 – 2.30 (m, 2H), 2.23 – 2.18 (m, 2H), 2.36 – 2.30 (m, 2H), 1.83 
(quint., J = 6.9 Hz, 2 H), 1.78 – 1.53 (m, 10H); 13C NMR (CD2Cl2, 75 MHz):  119.8, 99.1, 
82.2, 77.8, 67.2, 62.2, 31.2, 29.3, 26.2, 25.9, 25.4, 20.0, 18.8, 18.2, 16.4; MS (EI) m/z (rel 
intensity) 249 (<1), 181 (1), 166 (2), 148 (14), 131 (7), 120 (7), 101 (9), 85(100), 79 (11), 67 
(12), 56 (9), 41 (17); HR-MS (C15H13O2N+H): calcd. 250.180703, found 250.180949. Anal. 
calcd. for C15H23O2N (249.17): C, 72.25; H, 9.30; N, 5.62; found C, 72.46; H, 9.39; N, 5.72.  
1-Chloro-8-cyano-4-octyne: IR 2961, 2943, 2872, 2845, 2247, 1435, 1348, 1291, 859, 650; 
1H NMR (CD2Cl2, 300 MHz):  3.67 (t, J = 6.4 Hz, 2H), 2.48 (t, J = 2.6 Hz, 2H), 2.39 - 2.31 
(m, 4 H), 1.94 (quint., J = 6.4 Hz, 2H), 1.83 (quint., J = 6.8 Hz, 2H); 13C NMR (CD2Cl2, 75 
MHz):  119.7, 80.3, 78.7, 44.3, 31.9, 25.2, 18.1, 16.4, 16.3; MS (EI) m/z (rel intensity) 169 
(24), 141 (4), 132 (11), 120 (100), 106 (24), 91 (23), 79 (46), 65 (23), 51 (16), 39 (27), 27 
(21); HR-MS (C9H12NCl): calcd. 169.065827, found 169.065657. Anal. calcd. for C9H12NCl 
(169.07): C, 63.72; H, 7.13; N, 8.26; found C, 63.86; H, 7.18; N, 8.35.  
 S-6
7-[3-(tert-Butyl-dimethyl-silanyloxy)-5-oxo-2-(3-triethylsilanyloxy-oct-2-enyl)-cyclo-
pentyl]-hept-5-ynoic acid methyl ester ((−)-18a)> @ 20D  = −14.6 (c = 0.78, CHCl3). IR 2956, 
2929, 2858, 1748, 1607, 1464, 1252, 1110, 837, 776; 1H NMR (CD2Cl20+] 
(m, 1H), 5.73 - 5.55 (m, 2H), 4.20 - 4.08 (m, 1H), 3.66 (s, 3H), 2.90 - 2.55 (m, 2H), 2.41 (t, J 
= 7.4 Hz, 2H), 2.35 - 2.00 (m, 7H), 1.77 (dt, J = 14.4, 7.2 Hz, 2H), 1.60 - 1.19 (m, 7H), 1.05 - 
0.85 (m, 21H), 0.62 (q, J = 8.0 Hz, 6H), 0.08 (d, J = 4.0 Hz, 6H); 13C NMR (CD2Cl2, 75 
0+] 1, 52.2, 51.7, 
48.1, 39.0, 33.1, 32.3, 30.3, 25.9, 25.5, 24.6, 23.0, 18.4, 18.3, 17.1, 14.2, 7.1, 5.4, −4.5, −4.6; 
MS (EI) m/z (rel. intensity) 593 ([M+], 3), 563 (21), 535 (85), 521 (25), 460 (8), 431 (47), 389 
(65), 297 (21), 115 (30), 87 (58),75 (100), 59 (23); HR-MS (C33H60O5Si2 - C4H9): calcd. 
535.327506, found 535.327411; Anal. calcd. for C33H60O5Si2 (593.00): C, 66.84; H, 10.20; 
found C, 66.52; H, 10.18. 
7-[2-(3-Acetoxy-oct-1-enyl)-3-(tert-butyl-dimethyl-silanyloxy)-5-oxo-cyclopentyl]-hept-5-
ynoic acid methyl ester ((−)-18b): [ ] 20D  = −44.9 (c = 0.49, CHCl3). IR 2955, 2931, 2858, 
1742, 1631, 1437, 1372, 1244, 1117, 1018, 969, 839, 779; 1H NMR (CD2Cl2, 300 MHz):  
5.70 - 5.55 (m, 2H), 5.40 - 5.22 (m, 1H), 4.11 (dt, J = 13.5, 7.2 Hz, 1H), 3.66 (s, 3H), 2.80 - 
2.55 (m, 3 H), 2.41 (t, J = 7.4 Hz, 2H), 2.32 -1.95 (m, 9H), 1.77 (dt, J = 14.3, 7.1 Hz, 2H), 
1.45 -1.23 (m, 7H), 0.90 (m, 12H), 0.07 (s, 6H); 13C NMR (CD2Cl2, 75 MHz):  213.3, 
173.8, 170.3, 132.7, 132.7, 81.3, 77.5, 74.5, 72.9, 53.1, 53.1, 52.9, 51.7, 47.9, 34.9, 33.1, 31.9, 
25.9, 25.3, 24.6, 22.9, 21.4, 18.4, 18.3, 16.8, 14.1, −4.6, −4.7; MS (EI) m/z (rel intensity) 520 
(<1), 463 (12), 403 (31), 297 (18), 275 (19), 201 (14), 117 (32), 75 (100), 55 (27), 43 (60); 
HR-MS (C29H48O6Si+H): calcd. 521.329842, found 521.329390. Anal. calcd. for 
C29H48O6Si (520.77): C, 66.88; H, 9.29; found C, 66.65; H, 9.26.  
Prostaglandin E2 Methyl Ester ((−)-19). Colorless syrup. > @ 20D  = −69.2 (c = 0.49, CH3OH); 
[Lit.1 > @ 20D  = −71.8 (c = 1.31, CH3OH)]; IR (neat) 3420, 2954, 2931, 2859, 1742, 1437, 1245, 
1159, 1074, 970 cm-1. 1H NMR (300 MHz, CDCl3) δ 5.67 (1H, dd, J = 6.6, 15.3 Hz), 5.56 
(1H, dd, J = 8.0, 15.3 Hz), 5.36 (2H, m), 4.20-3.96 (2H, m), 3.67 (3H, s), 3.15 (1H, br. s), 
2.74 (1H, ddd, J = 0.9, 7.4, 18.5 Hz), 2.48-1.20 (20H, m), 0.89 (3H, t, J = 6.5 Hz); 13C NMR 
(75 MHz, CDCl3) δ 214.1, 174.2, 137.0, 131.0, 130.9, 126.5, 77.2, 77.0, 72.8, 72.1, 54.5, 
53.5, 51.6, 46.1, 37.3, 33.4, 31.7, 26.6, 25.2, 25.0, 24.7, 22.6, 14.0; MS (EI) m/z (rel intensity) 
366 ([M]+., 0.5), 348 ([M–H2O]+., 21), 330 (16), 277 (32), 245 (25), 208 (79), 190 (46), 164 
(86), 99 (76), 43 (100).  
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